Portfolio company
Nuclera
United Kingdom · £68.7m raised
Raised
£68.7m
Latest stage
Growth
Rounds recorded
1
Backed by
1 investor
Sectors
About
Nuclera manufactures benchtop systems for rapid protein expression and purification for use by researchers in the biotechnology and pharmaceutical industries.
SourceFunding history · 1
Similar companies
Proteomics
This company develops automated benchtop instruments for multiplexed protein analysis to assist researchers in the biotechnology and pharmaceutical industries.
Fluidic Sciences Ltd
This company manufactures microfluidic instruments and consumables for protein interaction analysis and single-cell screening to assist biopharmaceutical researchers with drug discovery.
Redshift Bio
This company manufactures analytical instruments and software for biopharmaceutical firms to measure the structure and concentration of proteins and other biomolecules.
Nplex Biosciences
This company develops high-throughput proteomics platforms for researchers in pharmaceutical and academic sectors to measure proteins for drug and biomarker discovery.
Portal Biotech
The company develops nanopore-based instruments for single-molecule protein sequencing to serve researchers in drug discovery, diagnostics and biosecurity sectors.
Accuri Cytometers
This company manufactures benchtop flow cytometers for life science researchers performing cell and bead analysis in academic, pharmaceutical and clinical laboratories.
Zephyrus Biosciences
This company develops single-cell protein analysis instruments and research tools for academic, biopharmaceutical and clinical scientists conducting disease research.
Nicoya
Nicoya develops surface plasmon resonance analytical instruments for researchers in the biotechnology and pharmaceutical industries to study molecular interactions and accelerate drug discovery.
